Metformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR) [+]/HER2[-] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICA
dc.conference.date | MAY 05-08, 2021 | |
dc.conference.title | ESMO Breast Cancer Virtual Congress | |
dc.contributor.author | Llombart Cussac, A. | |
dc.contributor.author | Perez-Garcia, J. M. | |
dc.contributor.author | Blanch, S. | |
dc.contributor.author | Tolosa, P. | |
dc.contributor.author | Ruiz Borrego, M. | |
dc.contributor.author | Gion Cortes, M. | |
dc.contributor.author | Fernadez, A. | |
dc.contributor.author | Urruticoechea, A. | |
dc.contributor.author | Galve, E. | |
dc.contributor.author | Cueva Banuelos, J. F. | |
dc.contributor.author | Ponce, J. | |
dc.contributor.author | Alonso, J. L. | |
dc.contributor.author | Capelan, M. | |
dc.contributor.author | Martinez, E. | |
dc.contributor.author | Bermejo De Las Heras, B. | |
dc.contributor.author | Rojas, B. | |
dc.contributor.author | Martos, T. | |
dc.contributor.author | Lopez, A. | |
dc.contributor.author | Gomez-Peralta, F. | |
dc.contributor.author | Cortes, J. | |
dc.contributor.authoraffiliation | [Llombart Cussac, A.] Hosp Arnau Vilanova, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Perez-Garcia, J. M.] Int Breast Canc Ctr IBCC, Quiron Grp, Med Oncol Dept, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Cortes, J.] Int Breast Canc Ctr IBCC, Quiron Grp, Med Oncol Dept, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Blanch, S.] Oncol Valencian Inst, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Tolosa, P.] Univ Hosp 12 Octubre, Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Ruiz Borrego, M.] Hosp Univ Virgen del Rocio, Med Oncol Dept, Seville, Spain | |
dc.contributor.authoraffiliation | [Gion Cortes, M.] Hosp Univ Ramon y Cajal, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Fernadez, A.] Hosp Duran & Reynals, ICO Inst Catala Oncol Hospitalet, Breast Canc, Lhospitalet De Llobregat, Spain | |
dc.contributor.authoraffiliation | [Urruticoechea, A.] Onkologikoa, Breast Canc, Donostia San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Galve, E.] Hosp Univ Basurto, OSI Bilbao Basurto, Med Oncol Dept, Bilbao, Spain | |
dc.contributor.authoraffiliation | [Cueva Banuelos, J. F.] CHUS Complejo Hosp Univ Santiago de Compostela SE, Dept Med Oncol, Santiago De Compostela, La Coruna, Spain | |
dc.contributor.authoraffiliation | [Ponce, J.] Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain | |
dc.contributor.authoraffiliation | [Alonso, J. L.] Hosp Clin Univ Virgen de la Arrixaca, IMIB Arrixaca, Med Oncol Dept, Murcia, El Palmar, Spain | |
dc.contributor.authoraffiliation | [Capelan, M.] Vall dHebron Inst Oncol VHIO, Breast Canc Grp, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Martinez, E.] Consorcio Hosp Prov Castellon, Med Oncol Dept, Castellon De La Plana, Spain | |
dc.contributor.authoraffiliation | [Bermejo De Las Heras, B.] Hosp Clin Univ Valencia, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Rojas, B.] HM CIOCC, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Martos, T.] Hosp del Mar, Med Oncol Dept, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Lopez, A.] Univ Hosp Leon, Med Oncol Dept, Leon, Spain | |
dc.contributor.authoraffiliation | [Gomez-Peralta, F.] Hosp Gen Segovia, Med Oncol Dept, Segovia, Spain | |
dc.contributor.funder | Novartis | |
dc.date.accessioned | 2025-01-07T15:32:43Z | |
dc.date.available | 2025-01-07T15:32:43Z | |
dc.date.issued | 2021-05-08 | |
dc.identifier.doi | 10.1016/j.annonc.2021.03.143 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753421010218/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27223 | |
dc.identifier.wosID | 648924400133 | |
dc.issue.number | 2 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S77-S77 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Metformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR) [+]/HER2[-] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICA | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |